Related Experiment Videos

[V-erbA oncogene, model of oncogenic activation of hormone receptor]

J Samarut1

  • 1Laboratoire de Biologie Moléculaire et Cellulaire, CNRS UMR49, INRA, Ecole Normale Supérieure de Lyon.

Annales D'Endocrinologie
|January 1, 1991
PubMed

Insights

The viral oncogene v-erbA, an altered thyroid hormone receptor, drives cancer by blocking cell differentiation and altering gene transcription. This discovery highlights hormone receptor roles in neoplastic transformation.

Area of Science:

  • Molecular biology
  • Oncology
  • Endocrinology

Context:

  • Avian leukemia retroviruses carry the viral oncogene v-erbA.
  • v-erbA is an altered form of the thyroid hormone T3 nuclear receptor.
  • This oncogene plays a role in neoplastic transformation.

Purpose:

  • To investigate the role of the viral oncogene v-erbA in neoplastic transformation.
  • To understand how v-erbA affects cell differentiation and gene transcription.
  • To explore the interaction of v-erbA with normal hormone receptors.

Summary:

  • The viral oncogene v-erbA, derived from the thyroid hormone T3 receptor, promotes sarcoma transformation and blocks erythrocyte progenitor cell differentiation.
  • The v-erbA protein acts as an antagonist to normal T3 and retinoic acid receptors.
  • It alters the transcription of genes regulated by intact receptors, impacting cell differentiation and proliferation.

Impact:

  • Demonstrates direct involvement of hormone receptors in cancer development.
  • Provides insights into mechanisms of oncogenesis driven by altered nuclear receptors.
  • Identifies potential therapeutic targets for hormone-dependent cancers.

Related Concept Videos